Alice Blue Home
URL copied to clipboard

Trending News

3 Pharma stocks in which promoters increased their pledge in Q3; Do you own any?

Promoters of three pharma stocks increased their pledged holdings in Q3, raising investor concerns. While it may support business needs, it also signals potential risks. Investors should assess the impact on their portfolios.

Promoter pledging is a key factor investors monitor, as it reflects a company’s financial health and management decisions. An increase in pledged shares can indicate the need for funds but may also raise concerns about financial stability and stock performance.

Alice Blue Image

In Q3, promoters of three pharma stocks raised their pledged holdings, catching investor attention. While this move might support business expansion or debt repayment, it can also pose risks if not managed well. Investors should analyze the implications before making investment decisions. Do you own any of these stocks?

Also Read: EV stock hits 5% lower circuit after announcing 1:10 stock split

Strides Pharma

On March 13, 2025, Strides Pharma Sciences Ltd opened at ₹609.00, down 0.31% from its previous close of ₹607.25. The stock reached a high of ₹610.4 (0.49%) and a low of ₹581.95. By 3:31 PM, it traded at ₹590.00 with a market cap of ₹2,306.55 crore.

In Q3, promoters of Strides Pharma Science Ltd pledged 5.08% of shares, bringing the total pledged shares to 54.25% of their holdings, raising investor concerns about financial leverage and potential risks in the company’s stability.

Strides Pharma Science Ltd (NSE: STAR) develops and manufactures pharmaceutical products sold in over 100 countries. With an inorganic growth strategy, it has expanded into new markets, therapy segments, and business areas while strengthening its manufacturing infrastructure.

Trident Lifeline

On March 13, 2025, Trident Lifeline Ltd opened at ₹263.00, up 5.41% from its previous close of ₹249.50. The stock reached a high of ₹263.50 (5.61%) and a low of ₹249.50. By 3:40 PM, it traded at ₹249.50, unchanged from the previous close, with a market cap of ₹286.91 crore.

In Q3, promoters of Trident Lifeline Ltd initiated pledging 3.46% of their holdings in the December 2024 quarter, raising concerns about financial strategies and potential risks associated with the company’s leveraged position in the pharmaceutical sector.

Trident Lifeline Ltd (BSE: 543616) manufactures and sells pharmaceutical products, operating through formulations, contract manufacturing, and an asset-light model. With a presence in 40 countries, it has 945 registered export products and 2,016 more under registration.

Also Read: Defence stock jumps after receiving export order worth ₹21.45 Cr for defence explosives

Solara Active Pharma

On March 13, 2025, Solara Active Pharma Sciences Ltd opened at ₹485.00, down 0.87% from its previous close of ₹489.25. The stock reached a high of ₹498.25 (1.84%) and a low of ₹475.05. By 3:41 PM, it traded at ₹480.00 with a market cap of ₹2,306.55 crore.

In the last quarter, promoters of Solara Active Pharma Sciences Ltd pledged 2.74% of shares, increasing the total pledged shares to 40.74% of their holdings, raising investor concerns about financial leverage and potential risks in the company.

Alice Blue Image

Solara Active Pharma Sciences Ltd (NSE: SOLARA) specializes in manufacturing, processing, and trading of active pharmaceutical ingredients (APIs). Formed via demerger from Strides Shasun Ltd, it later acquired Sequent Scientific Ltd’s human API business, becoming a dedicated API company.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

Loading
Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News
3 फार्मा स्टॉक्स जहां प्रमोटरों ने Q3 में गिरवी हिस्सेदारी बढ़ाई – क्या आपके पास इनमें से कोई स्टॉक है?

3 फार्मा स्टॉक्स जिनमें प्रमोटर्स ने Q3 में अपनी गिरवी हिस्सेदारी बढ़ाई; क्या आपके पास इनमें से कोई है?

3 फार्मा स्टॉक्स के प्रमोटरों ने Q3 में अपनी गिरवी रखी गई होल्डिंग्स बढ़ा दी, जिससे निवेशकों की चिंता बढ़ी।

*T&C apply